Navigation Links
Lumenis Launches HoLEP Preceptor Program at American Urology Association 2008 Annual Meeting
Date:5/12/2008

sicians on this technique and will continue to do so in the future."

"The clinical data supporting the superiority of the HoLEP procedure is significant," says Mr. Dov Ofer, Chief Executive Officer at Lumenis. "Lumenis must now commit to a comprehensive training program so that more urologists can become proficient with the HoLEP procedure and make it available to patients worldwide."

HoLEP is performed using Lumenis' VersaPulse(R) PowerSuite(TM) laser and morcellator systems. Mr. Lloyd Diamond, Senior Vice President and General Manager of Lumenis' Surgical Business stated, "PowerSuite was specifically designed to be a comprehensive clinical solution for urologists and their patients. It is truly a multi-purpose technology for the endoscopic treatment of stones, BPH, tumors and other soft tissue conditions. At this year's AUA meeting we will be highlighting the breadth of treatment options offered with a special emphasis on HoLEP."

Expert Physicians to Present in the Lumenis Booth at the AUA Meeting

Experienced thought-leading physicians will be at the Lumenis booth to present HoLEP and their own experiences using PowerSuite, including Drs. Richard David, Mitchell Humphreys, Tevita Aho, Lori Lerner and Evan Goldfischer. Presentations are scheduled throughout the duration of the AUA meeting. There will also be special small group roundtable discussions on HoLEP with these and other thought-leaders (registration required). For a complete list of speaker presentations and other Lumenis events, visit Lumenis booth #3901 at the American Urology Association meeting in the Orlando Convention Center, May 17-22, 2008. Or visit http://www.GetPowerSuite.com to see a complete presentation schedule and register for roundtable discussions.

About VersaPulse PowerSuite

The PowerSuite laser system, the first holmium laser cleared by the FDA for treatment of Benign Prostatic Hyperplasia
'/>"/>

SOURCE Lumenis Ltd.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Lumenis(R) Introduces the Newest Innovations in Fractional CO2 Laser Skin Therapy
2. Lumenis Ltd. Announces Senior Leadership Appointments Strengthening the Companys Strategic Businesses
3. Alma Lasers Answers Lumenis Complaint
4. Lumenis(R) Seeks Shareholder Approval of Proposed Class Action Settlement
5. Lumenis Sues Alma Lasers and its 4 founders for 200 Million Shekels
6. Lumenis Announces changes in Lumenis Vision Strategic Business Unit
7. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
8. UPMC Health Plan Launches New Personal Health Record
9. HealthInsuranceFinders.com Launches Video Contest for Young Directors
10. Academy of General Dentistry Launches Campaign to Focus on Tooth Erosion
11. Keeping Kids Healthy and Fit: The New York Kids Club Launches a Revolutionary New Fitness Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2008)...to Historic Low as Pharma Companies Face ...ONDON, July 24 /PRNewswire/ -- The Scientific busi...bility of the newly published CMR,International 20...eference,and business planning tool for decision m...siness strategy, marketing planning and corporate,...
(Date:7/23/2008)...ke Forest University Baptist Medical Center demons...fying patients who are having a heart attack, even..., The study used data from a registry called i*tr...oms who were admitted to emergency departments (ED...indings were released today in the Emergency Medi...
(Date:7/23/2008)... July 23 /PRNewswire-FirstCall/ - Cardiome Pharma ... it has entered into an,agreement with CR Intrinsi...CR Intrinsic Investors, LLC, an affiliate of S.A.C...rtible preferred shares for gross proceeds of,US$2...for general corporate,purposes, costs associated w...
(Date:7/23/2008)...ll/ -- The Hanover Insurance Group,a leading supe...nounced it,is prepared to respond to claims result...h southern Texas today., (Logo: http://www.newsc...re deeply concerned about individuals and business...t of The Hanover,s Central Region. "Our,staff is s...
Breaking Medicine News(10 mins):Health News:Thomson Reuters Publishes CMR International's 2008 Pharmaceutical R&D Factbook, Now Available for the First Time Online 2Health News:Study shows emergency physicians have good first instincts in diagnosing heart attacks 2Health News:Cardiome Announces Preferred Share Financing 2Health News:Cardiome Announces Preferred Share Financing 3Health News:The Hanover Ready to Serve Policyholders Impacted by Hurricane Dolly 2
...s organized crime that is on the brink of milking ... by foreigners to avail free medical treatment, ac...y. These phony deals have cost a mammoth $90 milli...ports.// The agency has reported a case of a Vic...
...cturers based at Washington have been blamed for n... effects of chromium exposure to the Government. /...eported. A paper submitted by George Washington ...ted the incomplete data published with respect to ...
...GELES - Doctors have revealed that the 7-month-old...ng heart transplant has shown good signs of recove...inues to fight for life.// Nick Draper was fitted...ration last week at the University of California, ...
...S. Environmental Protection Agency's National Air ... industrialized areas where air pollution is a way... The EPA, which// estimated the risk of developing...d result if a million people in a particular area ...
Other Medicine News:
(Date:7/22/2008)... and pegylated enzyme produces significantly en... - Pegylated enzyme well tolerated ...alozyme Therapeutics,Inc. (Nasdaq: HALO ), a bio...ing products targeting the extracellular matrix, t...inical animal efficacy data,for its pegylated-rHuP...
(Date:7/22/2008)...Approach of LASH (Laser Assisted Scar Healing)... MARSEILLES, France, July 22 /- Ekkyo...dicine company, which develops first-in-class,lase...tion, announced today,the publication of a scienti...orting the results of a pilot study on cutaneous s...
(Date:7/21/2008)... 2008 conferences, GAITHERSBURG, Md., July 21 /PR... company developing gene therapies for HIV and gen...6 Phase I and Phase II,clinical trials for the med...s an investigational gene therapy for the treatmen...rsday, July 24, 2008 at 11 a.m. EDT. The,presentat...
(Date:7/21/2008)...impedance spectroscopy (BIS) is,more accurate and ...ent of,lymphedema in breast cancer patients, accor...Journal of Clinical Oncology (2008; Vol. 26, Issue...t Cancer: Incidence, Risk Factors, and,Effect on U... Hayes, PhD.,and colleagues from Queensland Unive...
Breaking Medicine Technology:Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 2Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 3Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 4Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 5Ekkyo Describes the First Benefits of Controlled Hyperthermia in Humans in "Lasers in Surgery and Medicine" 2Ekkyo Describes the First Benefits of Controlled Hyperthermia in Humans in "Lasers in Surgery and Medicine" 3VIRxSYS to Host a Web Conference to Announce Clinical Trial Update 2VIRxSYS to Host a Web Conference to Announce Clinical Trial Update 3VIRxSYS to Host a Web Conference to Announce Clinical Trial Update 4VIRxSYS to Host a Web Conference to Announce Clinical Trial Update 5Bioimpedance Spectroscopy is More Accurate and Reliable Than Other Methods of Subclinical Assessment of Lymphedema in Breast Cancer Patients, According to Paper Published in Journal of Clinical Oncology 2Bioimpedance Spectroscopy is More Accurate and Reliable Than Other Methods of Subclinical Assessment of Lymphedema in Breast Cancer Patients, According to Paper Published in Journal of Clinical Oncology 3Into the wild 3447 1Life but not as we know it 3F 3443 1Life but not as we know it 3F 3443 2X rays often repeated for patients in developing countries 20385 1X rays often repeated for patients in developing countries 20385 2X rays often repeated for patients in developing countries 20385 3Renowned Leader and Educator in Robotic Cardiac Bypass Surgery Leverages Cardicas C Port 28R 29 Flex A 28R 29 Anastomosis System in His Practice and t 20381 1Renowned Leader and Educator in Robotic Cardiac Bypass Surgery Leverages Cardicas C Port 28R 29 Flex A 28R 29 Anastomosis System in His Practice and t 20381 2Renowned Leader and Educator in Robotic Cardiac Bypass Surgery Leverages Cardicas C Port 28R 29 Flex A 28R 29 Anastomosis System in His Practice and t 20381 3Renowned Leader and Educator in Robotic Cardiac Bypass Surgery Leverages Cardicas C Port 28R 29 Flex A 28R 29 Anastomosis System in His Practice and t 20381 4
...YTOWN, N.Y., June 15, 2007 /PRNewswire-FirstCall/ ... of scientific studies that,(1) demonstrate that A...ple types of human tumors in animal models, (2) re...cts, and (3) show that,MPC-6827 is not affected by...drug resistance. The study results appear in the J...
...HIGH WYCOMBE, England, June 18, 2007 /PRNewswire/ ...g how a new flu vaccine has the,potential to prote...demic and annual, was presented today by PepTcell,...VI (Options) Conference, in,Toronto, Canada. , The...the,European Journal of Immunology, showed how mic...
Other Medicine Technology:New Research Demonstrates Broad Efficacy of Azixa (MPC-6827),Against Multiple Tumor Types and in Drug Resistant Cell Lines 2New Research Demonstrates Broad Efficacy of Azixa (MPC-6827),Against Multiple Tumor Types and in Drug Resistant Cell Lines 3New Research Demonstrates Broad Efficacy of Azixa (MPC-6827),Against Multiple Tumor Types and in Drug Resistant Cell Lines 4New Research Demonstrates Broad Efficacy of Azixa (MPC-6827),Against Multiple Tumor Types and in Drug Resistant Cell Lines 5New Research Demonstrates Broad Efficacy of Azixa (MPC-6827),Against Multiple Tumor Types and in Drug Resistant Cell Lines 6New Flu Vaccine From PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 2New Flu Vaccine From PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 3New Flu Vaccine From PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 4
...DA Closure Device has been developed for the trans...troduced through standard venous sheaths (10-14F) ...he percutaneous closure of persistent ductal shunt...,An integral locking delivery and retrieval m...
Swanson Finger Pins are stainless steel and available in one length and three diameters.
Round Bevel-Point Hook Pin available in 2.3mm, 3.1mm, 4.7mm, and 6.3mm sizes.
Suture Passer is available with a 3/64 in. (.50 mm) hole in each end. Material: DePuy certified stainless steel. (sold in packs of six each)
Medicine Products: